Novartis to invest $700m to build cell culture plant
Swiss pharmaceutical giant Novartis will invest 700 million US dollars to build a cell culture production facility in Singapore, the government said Monday.
Construction of the facility -- Novartis' biggest investment to date in its manufacturing capacity -- is expected to start early next year and the plant should be operational by 2012, the Economic Development Board (EDB) said in a statement.
The plant will support clinical and commercial production of potential new products in biopharmaceutical therapies, the statement said.
On Monday, Novartis opened a 180 million US dollar facility in Singapore to manufacture tablets of existing Novartis brands.
Comments